Clin2
NCT07369115Possibly a fitNot yet recruiting

Lumateperone for depression with early life trauma

Major Depressive DiorderEarly Life Trauma

Treatments studied

Part of Mental health clinical trials.

This study tests whether adding lumateperone to your current antidepressant can help treat major depression that hasn't improved enough, especially if you experienced physical or sexual abuse before age 16. You'll have MRI scans and take the study drug for several weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
21 years to 70 years
Study type
Interventional

Who can take part

  • You are between 21 and 70 years old
  • You have major depression (without psychosis) and currently score at least 22 on a standard depression scale
  • You experienced physical or sexual assault before turning 16
  • You've been taking the same antidepressant for at least 6 weeks with less than 50% improvement
  • You can have an MRI (no metal implants, pacemaker, etc.)
  • You are not actively suicidal or at high risk for suicide

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07747389Not yet recruiting· Phase 3
Lumateperone for major depressive disorder

This study tests whether the drug lumateperone can help people with moderate to severe depression. If you join, you may receive the study drug or a placebo (a pill with no active medicine) to see if it improves your symptoms.

NCT07623135Recruiting· Phase 3
Lumateperone for Hard-to-Treat Depression in Older Adults

This study tests lumateperone, a new medication added to your current antidepressant, to help treat depression that hasn't improved with other treatments. It's designed for people age 60 and older who have tried at least two antidepressants without success.

Tucson, Arizona
NCT05850689Recruiting· Phase 3
Lumateperone add-on for major depression that didn’t improve

This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.

Huntsville, Alabama
NCT06372964Recruiting· Phase 3
Lumateperone for pediatric bipolar depression

This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.

Dothan, Alabama
NCT07699445Not yet recruiting· Phase 4
Lumateperone for weight and mood in bipolar depression

This study tests if lumateperone, a medication for bipolar depression, can also help with weight and aging in people with obesity. You may qualify if you have bipolar I depression and a body mass index (BMI) over 30.

Boston, Massachusetts
NCT06482554Recruiting· Phase 3
Lumateperone for Apathy in Psychotic Disorders

This trial tests a medication called lumateperone to see if it can improve apathy (lack of motivation) in people who have psychotic symptoms from schizophrenia or related disorders. It may help if you are already on a stable treatment but still struggle with apathy.

Shreveport, Louisiana

Hear when a new Major Depressive Diorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.